CA3197024A1 - Chimeric protein comprising the receptor binding domain of the coronavirus spike protein and compositions thereof - Google Patents

Chimeric protein comprising the receptor binding domain of the coronavirus spike protein and compositions thereof

Info

Publication number
CA3197024A1
CA3197024A1 CA3197024A CA3197024A CA3197024A1 CA 3197024 A1 CA3197024 A1 CA 3197024A1 CA 3197024 A CA3197024 A CA 3197024A CA 3197024 A CA3197024 A CA 3197024A CA 3197024 A1 CA3197024 A1 CA 3197024A1
Authority
CA
Canada
Prior art keywords
hbcag
crbdh6
protein
rbd
segment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3197024A
Other languages
English (en)
French (fr)
Inventor
Glay Chinea Santiago
Alejandro Miguel Martin Dunn
Diamile Gonzalez Roche
Miladys Limonta Fernandez
Enrique Iglesias Perez
Monica Bequet Romero
Hector Santana Milian
Gabriel J. Marquez Perera
Alexis Musacchio Lasa
Ania Cabrales Rico
Gerardo Enrique Guillen Nieto
Marta Ayala Avila
Eulogio Pimentel Vazquez
Gertrudis Rojas Dorantes
Vivian Huerta Galindo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centro de Ingenieria Genetica y Biotecnologia CIGB
Original Assignee
Centro de Ingenieria Genetica y Biotecnologia CIGB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro de Ingenieria Genetica y Biotecnologia CIGB filed Critical Centro de Ingenieria Genetica y Biotecnologia CIGB
Publication of CA3197024A1 publication Critical patent/CA3197024A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20071—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA3197024A 2020-11-04 2021-11-03 Chimeric protein comprising the receptor binding domain of the coronavirus spike protein and compositions thereof Pending CA3197024A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU2020000081A CU24665B1 (es) 2020-11-04 2020-11-04 Proteína quimérica que comprende el dominio de unión al receptor de la proteína de la espiga de coronavirus y composiciones que las comprenden
CU2020-0081 2020-11-04
PCT/CU2021/050010 WO2022096039A1 (es) 2020-11-04 2021-11-03 Proteina quimerica que comprende el dominio de union al receptor de la proteina de la espiga de corona virus y composiciones que las comprenden

Publications (1)

Publication Number Publication Date
CA3197024A1 true CA3197024A1 (en) 2022-05-12

Family

ID=79164940

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3197024A Pending CA3197024A1 (en) 2020-11-04 2021-11-03 Chimeric protein comprising the receptor binding domain of the coronavirus spike protein and compositions thereof

Country Status (12)

Country Link
US (1) US20230405106A1 (https=)
EP (1) EP4242222A1 (https=)
JP (1) JP2023548205A (https=)
CN (1) CN116802194A (https=)
AR (1) AR123998A1 (https=)
AU (1) AU2021373188A1 (https=)
CA (1) CA3197024A1 (https=)
CO (1) CO2023004963A2 (https=)
CU (1) CU24665B1 (https=)
MX (1) MX2023005211A (https=)
WO (1) WO2022096039A1 (https=)
ZA (1) ZA202304779B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025519107A (ja) * 2022-05-23 2025-06-24 バクスディグム カンパニー，リミティド ウイルスヌクレオカプシドを用いた結晶性タンパク質ベースの標的タンパク質融合自己組織化ナノ粒子製造プラットフォーム
WO2023229330A1 (ko) * 2022-05-23 2023-11-30 주식회사 백스다임 바이러스 뉴클레오캡시드를 이용한 오량체형 독소 단백질 기반 목적 단백질 융합 오량체 제조 플랫폼

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111217918B (zh) * 2020-03-04 2020-11-10 中山大学 一种基于2,4-二氧四氢喋啶合酶的新型冠状病毒s蛋白双区域亚单位纳米疫苗
CN111366734B (zh) * 2020-03-20 2021-07-13 广州市康润生物科技有限公司 双指标筛选新冠病毒及预判重型肺炎的方法
CN111620952A (zh) * 2020-06-17 2020-09-04 苏州米迪生物技术有限公司 基于嵌合型病毒样颗粒的新型冠状病毒疫苗
CN111676248A (zh) * 2020-07-02 2020-09-18 军事科学院军事医学研究院军事兽医研究所 表达新型冠状病毒S基因与流感M1基因嵌合SARS-CoV-2 VLP的构建

Also Published As

Publication number Publication date
CU24665B1 (es) 2023-06-13
US20230405106A1 (en) 2023-12-21
AR123998A1 (es) 2023-02-01
MX2023005211A (es) 2023-05-16
EP4242222A1 (en) 2023-09-13
JP2023548205A (ja) 2023-11-15
AU2021373188A1 (en) 2023-06-01
CO2023004963A2 (es) 2023-06-20
WO2022096039A1 (es) 2022-05-12
AU2021373188A9 (en) 2024-10-10
CN116802194A (zh) 2023-09-22
ZA202304779B (en) 2024-09-25
CU20200081A7 (es) 2022-06-06

Similar Documents

Publication Publication Date Title
US10421789B2 (en) Engineered outer domain (EOD) of HIV GP120 and mutants thereof
JP2023524054A (ja) ベータコロナウイルスの予防と治療
McGaughey et al. Progress towards the development of a HIV-1 gp41-directed vaccine
Cruz et al. A comparative study of different presentation strategies for an HIV peptide immunogen
US20230405106A1 (en) Chimeric protein comprising the receptor binding domain of the corona virus spike protein and compositions comprising them
CN104507496B (zh) 包含与crm197载体蛋白偶联的hiv gp41肽的免疫原性化合物
CA3193288A1 (en) Immunogenic coronavirus fusion proteins and related methods
Park et al. Development of self-assembled protein nanocage spatially functionalized with HA stalk as a broadly cross-reactive influenza vaccine platform
AU2022366884A1 (en) Engineering antigen binding to, and orientation on, adjuvants for enhanced humoral responses and immunofocusing
JP4202574B2 (ja) ｇｐ１２０に親和性を有するぺプチド
JP2024502823A (ja) 安定なコロナウィルスタンパク質およびそのワクチン組成物
EP1704167B1 (en) A method to make a peptide-carrier conjugate with a high immunogenicity
CN100387616C (zh) 获得可增强特异交叉反应性的抗原结构的方法
US11072638B2 (en) Immunostimulating peptides
KR101756202B1 (ko) 신규한 ｇｐ41 항원
CN115916237A (zh) 抗病毒病原体的疫苗
Rojo Dendritic compounds as immune response modulators. New approaches for vaccine development
Cruz et al. Enhanced immunogenicity and cross-reactivity of HIV-1 V3-peptide and multiple antigen peptides conjugated to distinct carrier proteins
JP4203082B2 (ja) ｇｐ１２０に親和性を有するぺプチド
Di Vincenzo Determinants of the Antibody Response against HIV Env induced by Nanoparticle Vaccination and Intrastructural Help
JPH10182696A (ja) ｇｐ１２０に対して親和性を有するペプチド
Ramirez Engineering Protein-Based Nanoparticles for Infectious Disease Vaccine Development
Pho Surface Engineering of Protein Nanoparticles for Intranasal Delivery
JPH10182695A (ja) ｇｐ１２０に対して親和性を有するペプチド
CN121311240A (zh) 基于dna折纸技术的亚单位疫苗

Legal Events

Date Code Title Description
MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240930

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240930

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240930

P22 Classification modified

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P22-P110 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CLASSIFICATION MODIFIED

Effective date: 20241216

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251217